Stockscreener 앱 받기
7.66
11.34%
0.78
시간 외 거래:
7.66
전일 마감가:
$6.88
열려 있는:
$6.9
하루 거래량:
595.07K
Relative Volume:
0.92
시가총액:
$414.34M
수익:
$2.81M
순이익/손실:
$-97.34M
주가수익비율:
-4.8481
EPS:
-1.58
순현금흐름:
$-91.47M
1주 성능:
+18.21%
1개월 성능:
+11.34%
6개월 성능:
+135.69%
1년 성능:
-11.24%
1일 변동 폭
$6.85
$7.87
1주일 범위
$6.35
$7.87
52주 변동 폭
$2.315
$9.30
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
명칭
Fulcrum Therapeutics Inc
전화
617-651-8851
주소
26 LANDSDOWNE STREET, CAMBRIDGE, MA
FULC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
7.66 | 372.15M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-09-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-09-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-05-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2023-09-25 | 개시 | Goldman | Neutral |
| 2023-08-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | 업그레이드 | Stifel | Hold → Buy |
| 2023-05-04 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-03-10 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-02-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-11-15 | 개시 | Goldman | Buy |
| 2022-03-08 | 개시 | Oppenheimer | Outperform |
| 2022-03-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-08-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-03-22 | 개시 | Credit Suisse | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2020-10-16 | 개시 | Piper Sandler | Overweight |
| 2020-08-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-08-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2019-10-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-12 | 개시 | BofA/Merrill | Buy |
모두보기
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
Will Fulcrum Therapeutics Inc. price bounce be sustainableJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser
How volatile is Fulcrum Therapeutics Inc. stockWatch List & AI Optimized Trade Strategies - خودرو بانک
Can Fulcrum Therapeutics Inc. weather a recessionJuly 2025 Retail & Entry Point Confirmation Alerts - خودرو بانک
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.July 2025 Sector Moves & Free Community Supported Trade Ideas - Newser
Does Fulcrum Therapeutics Inc. show high probability of reboundJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
What institutional flow reveals about Fulcrum Therapeutics Inc.July 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
Combining machine learning predictions for Fulcrum Therapeutics Inc.July 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser
What is Fulcrum Therapeutics Inc.’s TAM (Total Addressable Market)July 2025 News Drivers & Low Drawdown Trading Strategies - خودرو بانک
Will Fulcrum Therapeutics Inc. benefit from macro trendsTake Profit & Fast Exit/Entry Strategy Plans - Newser
Fulcrum Therapeutics Inc. stock daily chart insightsJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Fulcrum Therapeutics at Cantor Global Healthcare Conference: Renewed Hope in Sickle Cell - Investing.com Canada
What’s Fulcrum Therapeutics Inc.’s historical return2025 Market WrapUp & Long Hold Capital Preservation Plans - خودرو بانک
Is Fulcrum Therapeutics Inc. stock reversal real or fakeJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Earnings Recap Report & Real-Time Volume Triggers - Newser
Relative strength of Fulcrum Therapeutics Inc. in sector analysis2025 Price Targets & Weekly High Momentum Picks - Newser
How sentiment analysis helps forecast Fulcrum Therapeutics Inc.July 2025 Setups & Trade Opportunity Analysis Reports - Newser
Is this a good reentry point in Fulcrum Therapeutics Inc.Earnings Summary Report & Free Community Consensus Stock Picks - Newser
Does Fulcrum Therapeutics Inc. qualify in momentum factor screening2025 Dividend Review & Risk Controlled Daily Trade Plans - Newser
Will Fulcrum Therapeutics Inc. outperform during market ralliesJuly 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
What’s the recovery path for long term holders of Fulcrum Therapeutics Inc.July 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Will Fulcrum Therapeutics Inc. see short term momentumMarket Trend Review & Free Daily Entry Point Trade Alerts - Newser
Sector ETF performance correlation with Fulcrum Therapeutics Inc.Weekly Profit Summary & Consistent Income Trade Ideas - Newser
Custom watchlist performance reports with Fulcrum Therapeutics Inc.Portfolio Update Report & High Yield Stock Recommendations - Newser
Exit strategy if you’re trapped in Fulcrum Therapeutics Inc.July 2025 Market Mood & Low Risk High Reward Trade Ideas - Newser
Fulcrum Therapeutics Inc. stock prediction for this weekPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
How high can Fulcrum Therapeutics Inc. stock goJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Technical Models Suggest Fulcrum Therapeutics Inc. May Rebound Soon2025 Sector Review & Daily Growth Stock Investment Tips - beatles.ru
What institutional flow reveals about Fulcrum Therapeutics IncEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Market reaction to Fulcrum Therapeutics Inc.’s recent newsQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Is Fulcrum Therapeutics Inc. vulnerable to short sellers2025 AllTime Highs & Reliable Volume Spike Trade Alerts - خودرو بانک
Strategies to average down on Fulcrum Therapeutics Inc.Weekly Gains Report & Verified Momentum Stock Alerts - Newser
What is the dividend yield of Fulcrum Therapeutics Inc.July 2025 Intraday Action & Consistent Profit Focused Trading Strategies - خودرو بانک
Will Fulcrum Therapeutics Inc. outperform tech stocksEarnings Summary Report & Weekly Sector Rotation Insights - خودرو بانک
Will earnings trigger a reversal in Fulcrum Therapeutics Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser
Using Bollinger Bands to evaluate Fulcrum Therapeutics Inc.July 2025 Catalysts & Consistent Income Trade Recommendations - Newser
Is Fulcrum Therapeutics Inc. in a bullish channelQuarterly Investment Review & High Conviction Trade Alerts - خودرو بانک
Is Fulcrum Therapeutics Inc. reversing from oversold territoryCPI Data & Reliable Breakout Forecasts - Newser
Fulcrum Therapeutics Inc (FULC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):